Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
02/03/2023 | Cyteir Therapeutics, Inc. | CYT | Grant | Stock Option (Right to Buy) | 14.2k | $1.69 | $23.9k | | 02/03/2023 |
02/22/2022 | Cyteir Therapeutics, Inc. | CYT | Grant | Stock Option (Right to Buy) | 14.2k | $5.96 | $84.3k | | 02/22/2022 |
06/22/2021 | Cyteir Therapeutics, Inc. | CYT | Conversion | Common Stock | 2.4M | $0.00 | $0 | See Footnote | 06/22/2021 |
06/22/2021 | Cyteir Therapeutics, Inc. | CYT | Conversion | Series B Convertible Preferred Stock | 7.5M | $0.00 | $0 | See Footnote | 06/22/2021 |
06/22/2021 | Cyteir Therapeutics, Inc. | CYT | Conversion | Series C Convertible Preferred Stock | 832k | $0.00 | $0 | See Footnote | 06/22/2021 |
06/11/2021 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 20k | $2.28 | $45.6k | | 06/11/2021 |
06/09/2020 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 20k | $5.25 | $105k | | 06/09/2020 |
01/22/2020 | ACCELERON PHARMA INC | XLRN | Grant | Option to Purchase Common Stock | 8.2k | $52.99 | $433.7k | | 01/22/2020 |
01/22/2020 | ACCELERON PHARMA INC | XLRN | Grant | Common Stock | 1.4k | $0.00 | $0 | | 01/22/2020 |
06/28/2019 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 11.8k | $41.17 | $486.3k | See Footnote | 06/26/2019 |
06/26/2019 | ACCELERON PHARMA INC | XLRN | Other (acquisition) | Common Stock | 11.8k | $0.00 | $0 | See Footnote | 06/26/2019 |
06/26/2019 | ACCELERON PHARMA INC | XLRN | Other (disposition) | Common Stock | 11.8k | $0.00 | $0 | | 06/26/2019 |
06/26/2019 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 25.7k | $39.16 | $1M | | 06/26/2019 |
06/26/2019 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 7.5k | $30.17 | $226.3k | | 06/26/2019 |
06/26/2019 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 10k | $27.97 | $279.7k | | 06/26/2019 |
06/26/2019 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 20k | $24.11 | $482.2k | | 06/26/2019 |
05/30/2019 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 11k | $5.42 | $59.6k | | 05/30/2019 |
01/25/2019 | ACCELERON PHARMA INC | XLRN | Grant | Common Stock | 1.2k | $0.00 | $0 | | 01/25/2019 |
01/25/2019 | ACCELERON PHARMA INC | XLRN | Grant | Option to Purchase Common Stock | 7.5k | $41.64 | $312.3k | | 01/25/2019 |
06/07/2018 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 14k | $1.48 | $20.7k | | 06/07/2018 |
05/31/2018 | Calithera Biosciences, Inc. | CALA | Grant | Stock Option (Right to Buy) | 11k | $5.15 | $56.6k | | 05/31/2018 |
03/01/2018 | ACCELERON PHARMA INC | XLRN | Grant | Common Stock | 1.2k | $0.00 | $0 | | 03/01/2018 |
03/01/2018 | ACCELERON PHARMA INC | XLRN | Grant | Option to Purchase Common Stock | 7.5k | $40.61 | $304.6k | | 03/01/2018 |
12/15/2017 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 105.1k | $35.73 | $3.8M | See footnote | 12/15/2017 |
07/27/2017 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 6.5k | $1.27 | $8.3k | | 07/27/2017 |
09/30/2016 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 857.1k | $35.50 | $30.4M | See footnotes | 09/30/2016 |
03/03/2016 | ACCELERON PHARMA INC | XLRN | Grant | Option to Purchase Common Stock | 10k | $27.97 | $279.7k | | 03/03/2016 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 27.9k | $0.00 | $0 | Advanced Technology Ventures VII (C), L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 1.4M | $0.00 | $0 | Advanced Technology Ventures VII, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Common Stock | 8.6k | $0.00 | $0 | ATV Entrepreneurs VII, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 37.4k | $0.00 | $0 | Advanced Technology Ventures VII (B), L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 18k | $0.00 | $0 | Advanced Technology Ventures VII (C), L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series B Preferred Stock | 931.5k | $0.00 | $0 | Advanced Technology Ventures VII, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series C Preferred Stock | 431.2k | $0.00 | $0 | Advanced Technology Ventures VII, L.P. | 05/28/2013 |
05/28/2013 | PORTOLA PHARMACEUTICALS INC | PTLA | Conversion | Series C Preferred Stock | 2.6k | $0.00 | $0 | ATV Entrepreneurs VII, L.P. | 05/28/2013 |
|